Billionaires are funding the creation of life-extending pills that will eventually hit the market for people to buy, according to a CEO — and he says it’ll turn the rich in to “posh, privileged zombies.”
The chilling warning comes amid fears that AI and biotechnology are evolving at such a rapid pace that anti-aging tablets might only be a matter of years away.
Amazon boss Jeff Bezos, PayPal co-founder Peter Thiel and ChatGPT’s Sam Altman are among the latest in a long line of American tycoons to throw their wealth behind regenerative medicine.
Bezos is reported to have invested $3 billion — the biggest biotechnology company launch of all time — in Altos Labs, which he cofounded with Russian-born billionaire Yuri Milner in 2021.
The startup hired top scientists to research how to reverse the aging process and pursue something called biological reprogramming technology, which would allow scientists to rejuvenate cells in a lab.
According to MIT Technology Review, Altos Labs immediately drew comparisons to Calico Labs, a similar company that Google co-founder Larry Page started in 2013 to focus on longevity and reprogramming.
They’re not the only billionaires on an anti-aging quest: PayPal co-founder Peter Thiel invested in the Methuselah Foundation, which describes itself as “a non-profit medical charity focused on extending the healthy human lifespan by making 90 the new 50.”
Among Methuselah’s goals are to invent technologies that can create new organs, blood vessels, and bones; to remove “destructive biological structures” from the body; to further studies of epigenetics; and to restore things like cognition and physical ability in older people.
Most recently, in April last year, ChatGPT founder Sam Altman was revealed to have funded biotech startup Retro BioScience to the tune of $180 million.
According to its website, Retro BioScience focuses on “cellular reprogramming” and is less than four years away from developing a clinical proof-of-concept. It vows to extend human life by 10 years.
In July, researchers at MRC Laboratory of Medical Science at Imperial College London and Duke-NUS Medical School in Singapore announced the discovery of a new drug that increased the lifespans of laboratory mice by nearly 25%.
Their aim is to increase life expectancy with drugs and other technologies that make the body’s cells stay younger and disease-free for longer.
“At the rate technology is evolving, it will only be a matter of time before life-extending drugs become freely available to those who can afford them,” said Phil Cleary, the founder of the SmartWater Group.
